• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pCEA在细针穿刺活检诊断肝细胞癌中的胆小管免疫染色。

pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma.

作者信息

Wee A, Nilsson B

机构信息

Department of Pathology, National University Hospital, National University of Singapore, Republic of Singapore.

出版信息

Acta Cytol. 1997 Jul-Aug;41(4):1147-55. doi: 10.1159/000332837.

DOI:10.1159/000332837
PMID:9250313
Abstract

OBJECTIVE

To assess the usefulness of bile canalicular polyclonal carcinoembryonic antigen (pCEA) immunostaining in fine needle aspiration biopsy (FNAB) diagnosis of hepatocellular carcinoma (HCC).

STUDY DESIGN

Hepatic FNAB with cell blocks of 72 confirmed and 6 possible HCC and 23 non-HCC malignancies (controls) were analyzed. Sections were stained with antibody to pCEA using the streptavidin biotin-immunoperoxidase method and results correlated with tumor grade and other parameters used in HCC diagnosis.

RESULTS

Canalicular pCEA staining was observed in 60 (83%) of the 72 HCC. This category comprised 29%, 31%, 36% and 4% grade 1-4 tumors, including 7 small cell, 4 clear cell and 1 giant cell variants. With increasing anaplasia, the canaliculi became infrequent, irregularly distributed, and increasingly distorted and interrupted. Canalicular staining helped distinguish clear and small cell variants from metastatic renal cell carcinomas and neuroendocrine tumors, respectively. Of the six problematic cases, one was confirmed to be HCC with plasmacytoid features and five to be adenocarcinomas, of which three could have been combined hepatocellular-cholangiocarcinomas. Liver cell dysplasia also displayed an abnormal canalicular pattern. No cytoplasmic staining was seen in pure HCC.

CONCLUSION

pCEA immunostaining cannot separate malignant, dysplastic or benign hepatocytes. It is usually not required in cytodiagnosis of most HCC. However, it is most helpful in confirming atypical variants of HCC, which may mimic other tumors.

摘要

目的

评估胆管多克隆癌胚抗原(pCEA)免疫染色在细针穿刺活检(FNAB)诊断肝细胞癌(HCC)中的作用。

研究设计

对72例确诊的和6例可能的HCC以及23例非HCC恶性肿瘤(对照)的肝细针穿刺活检及细胞块进行分析。采用链霉亲和素生物素免疫过氧化物酶法用抗pCEA抗体对切片进行染色,并将结果与肿瘤分级及HCC诊断中使用的其他参数相关联。

结果

72例HCC中有60例(83%)观察到胆管pCEA染色。此类包括1 - 4级肿瘤的29%、31%、36%和4%,其中包括7例小细胞、4例透明细胞和1例巨细胞变体。随着间变程度增加,胆管变得稀少、分布不规则且越来越扭曲和中断。胆管染色有助于分别将透明细胞和小细胞变体与转移性肾细胞癌和神经内分泌肿瘤区分开来。在6例疑难病例中,1例被确诊为具有浆细胞样特征的HCC,5例为腺癌,其中3例可能是肝细胞 - 胆管细胞癌合并症。肝细胞发育异常也表现出异常的胆管模式。在纯HCC中未见胞质染色。

结论

pCEA免疫染色不能区分恶性、发育异常或良性肝细胞。在大多数HCC的细胞诊断中通常不需要。然而,它在确认可能模仿其他肿瘤的HCC非典型变体方面最有帮助。

相似文献

1
pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma.pCEA在细针穿刺活检诊断肝细胞癌中的胆小管免疫染色。
Acta Cytol. 1997 Jul-Aug;41(4):1147-55. doi: 10.1159/000332837.
2
Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.多克隆癌胚抗原染色在原发性和转移性肝脏恶性肿瘤的细胞学鉴别诊断中的应用
Acta Cytol. 1991 Mar-Apr;35(2):215-20.
3
Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.用CD34和癌胚抗原对肝脏细针穿刺活检组织进行双色免疫染色。在原发性肝细胞癌与转移性肿瘤诊断中的潜在应用。
Anal Quant Cytol Histol. 2004 Apr;26(2):61-4.
4
Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates.多克隆和单克隆抗癌胚抗原抗体在肝脏细针穿刺抽吸物中的应用。
Diagn Cytopathol. 1994 Dec;11(4):358-61; discussion 361-2. doi: 10.1002/dc.2840110409.
5
[Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].[白蛋白信使核糖核酸和癌胚抗原在肝细胞癌组织病理学诊断中的应用]
Pathologica. 1999 Aug;91(4):260-7.
6
Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.肝脏原发性癌与转移性癌的免疫组织化学对比研究。
Am J Clin Pathol. 1993 May;99(5):551-7. doi: 10.1093/ajcp/99.5.551.
7
HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.利用HepPar1、MOC-31、pCEA、mCEA和CD10鉴别肝细针穿刺抽吸物中的肝细胞癌与转移性腺癌。
Acta Cytol. 2006 May-Jun;50(3):257-62. doi: 10.1159/000325951.
8
Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.免疫过氧化物酶染色作为肝细胞癌的诊断辅助手段。
Mod Pathol. 1989 Jan;2(1):8-12.
9
Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.CD10在肝脏细针穿刺活检(FNAB)中鉴别肝细胞癌与转移性癌的诊断效用
Diagn Cytopathol. 2004 Feb;30(2):92-7. doi: 10.1002/dc.10419.
10
Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas.多克隆癌胚抗原在肝细胞癌中的免疫细胞化学定位
Acta Cytol. 1991 Mar-Apr;35(2):221-4.

引用本文的文献

1
Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma.肝脏细针穿刺活检:肝细胞癌诊断的算法方法及当前问题
Cytojournal. 2005 Jun 8;2:7. doi: 10.1186/1742-6413-2-7.
2
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.一种新型诊断标志物p28GANK可将肝细胞癌与潜在的类似疾病区分开来。
J Cancer Res Clin Oncol. 2004 Sep;130(9):514-20. doi: 10.1007/s00432-004-0562-y. Epub 2004 Jun 19.
3
Fine needle aspiration biopsy of liver - an update.
肝脏细针穿刺活检——最新进展
World J Surg Oncol. 2004 Mar 16;2:5. doi: 10.1186/1477-7819-2-5.